/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.23%
Natural Gas
+8.04%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.32%
VIX
N/A
Economic Calendar
EUR/USD
+0.23%
Natural Gas
+8.04%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.32%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Crypto Token Unlocks: AVAX, ARB, PYTH to Distribute $3 Billion in May 2024
about 2 hours ago
Dallas Fed Manufacturing Index Drops To -14.5 In April, Missing Analyst Expectations
about 7 hours ago
Eurozone Economic Sentiment Indicator Falls to 95.6 in April
about 13 hours ago
Bitcoin ETFs: After Record $328M Outflows, What Happens Next?
1 day ago
Vitalik Buterin Backs Ethereum PoS Transition amid Community Debates
1 day ago
Crypto Market Outlook: BTC, SOL, ETH, DOGE Face Downward Pressure
1 day ago
Octa’s Market Snapshot: The Fed Is Stuck Between Recession and High Inflation
about 2 hours ago
Gold Price Forecast: Struggles Amid Technical Challenges
about 2 hours ago
Natural Gas Price Forecast: Bullish Momentum Continues
about 2 hours ago
Ethereum (ETH) Price Forecast: Imminent Rebound to $3,500?
about 2 hours ago
NASDAQ Index, SP500, Dow Jones Forecasts – SP500 Is Mostly Flat Despite Tesla’s Rally
about 3 hours ago
Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Pulls Back On Israel – Hamas Ceasefire Talks
about 4 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
ROIV
news
Roivant Sciences Ltd
Follow
ROIV
(
Nasdaq - US
)
N/A
11.13
+0.10 (+0.91%)
in
:
usd
•
As of: Apr 29, 2024 15:59
UTC -4
Open
11.03
High
11.27
Low
11.02
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Investors Business Daily
Apr 2, 2024
Roivant Sciences Stock Flirts With Breakout On 'Extremely Positive' Eye-Disease Study
ROIV
+0.91%
Seeking Alpha
Mar 18, 2024
Roivant Sciences: $7bn Televant Sale Sets It Up For Long-Term Success
ROIV
+0.91%
Seeking Alpha
Feb 13, 2024
Roivant Sciences Ltd. (ROIV) Q3 2023 Earnings Call Transcript
ROIV
+0.91%
Seeking Alpha
Jan 7, 2024
Roivant Sciences: Why Its 'Vant' Biotech Model Is A Buy
ROIV
+0.91%
Market Watch
Nov 27, 2023
Roivant Sciences shares drop as lupus treatment misses trial goal
ROIV
+0.91%
Seeking Alpha
Nov 14, 2023
Roivant Sciences Ltd. (ROIV) Q2 2023 Earnings Call Transcript
ROIV
+0.91%
Seeking Alpha
Oct 24, 2023
Roivant Sciences: Risk-Transforming Deal Met With Crickets
ROIV
+0.91%
The Motley Fool
Oct 24, 2023
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
ROIV
+0.91%
Investopedia
Oct 23, 2023
Roivant Sciences Sells Joint Venture With Pfizer to Roche for $7.1 Billion
ROIV
+0.91%
PFE
+0.98%
InvestorPlace
Oct 23, 2023
Why Is Roivant Sciences (ROIV) Stock Up Today?
ROIV
+0.91%
Market Watch
Oct 23, 2023
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
ROIV
+0.91%
PFE
+0.98%
Market Watch
Oct 23, 2023
Morgan Stanley's Wilson: Next rally attempt will fail as investors are punishing earnings reports.
ROIV
+0.91%
AAPL
+2.48%
PFE
+0.98%
WSJ
Oct 23, 2023
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
ROIV
+0.91%
PFE
+0.98%
Invezz
Oct 23, 2023
Roivant Sciences stock: Good news for Vivek Ramaswamy
ROIV
+0.91%
The Motley Fool
Oct 1, 2023
3 No-Brainer Growth Stocks to Buy in October
ROIV
+0.91%
DKNG
-0.77%
Zacks Investment Research
Sep 27, 2023
Roivant Sciences Ltd. (ROIV) Moves 21.6% Higher: Will This Strength Last?
ROIV
+0.91%
Invezz
Sep 27, 2023
Roivant stock price outlook: strong pipeline is a catalyst
ROIV
+0.91%
The Motley Fool
Sep 26, 2023
These 2 Biotech Stocks Are Bucking a Down Market Tuesday
ROIV
+0.91%
IMVT
+1.29%
Seeking Alpha
Sep 11, 2023
Skin In The Game: Behind Roivant's Significant Rise
ROIV
+0.91%
Invezz
Sep 9, 2023
Roivant Sciences: Is this Vivek Ramaswamy's biotech stock a buy?
ROIV
+0.91%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker